Benzinga’s Top Ratings Upgrades, Downgrades For September 14, 2023
Upgrades According to OTR Global, the prior rating for Align Technology Inc (NASDAQ:ALGN) was changed from Mixed to…
Cancer Focused Immunocore Leads The Way In TCR Therapeutics, Positioned For Success: Analyst Says
Needham has initiated coverage on Immunocore Holdings Plc (NASDAQ: IMCR) with a Buy rating and
Benzinga’s Top Ratings Upgrades, Downgrades For September 13, 2023
Upgrades For Southern Co (NYSE:SO), B of A Securities upgraded the previous rating of Underperform to Neutral. For…
Benzinga’s Top Ratings Upgrades, Downgrades For September 12, 2023
Upgrades RBC Capital upgraded the previous rating for Equinox Gold Corp (AMEX:EQX) from Underperform to Sector Perform. In…
Bank Of America Is Bullish On Raymond James: ‘Diversified Approach Shines Through’
In a sector where fluctuating rates often dictate profits, Raymond James Financial (NYSE: RJF) is showing some resilience, underpinned by a diversified profit model that's envied by many of its interest-rate dependent peers.
Benzinga’s Top Ratings Upgrades, Downgrades For September 11, 2023
Upgrades Bernstein upgraded the previous rating for Brown-Forman Corp (NYSE:BF) from Market Perform to Outperform. For Nu Holdings…
EVgo’s Challenges Ahead: Analyst On How Price Competition And Regulatory Credits Could Impact Margins And Returns
RBC Capital Markets analyst Chris Dendrinos initiated coverage on EVgo Inc (NASDAQ: EVGO) with a Sector Perform rating
Microcap Firm ZyVersa Therapeutics Shows Promise Despite IPO Volatility, Analyst Initiates With Buy
HC Wainwright initiated coverage on ZyVersa Therapeutics Inc (NASDAQ: ZVSA) with a Buy Rating and a
Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst
Cantor Fitzgerald has initiated coverage of Atossa Therapeutics Inc (NASDAQ: ATOS) with an Overweight rating and
ChargePoint’s Asset-Light Strategy: Analyst On What It Means For Future Revenue And EPS
RBC Capital Markets analyst Chris Dendrinos initiated coverage on ChargePoint Holdings Inc (NYSE: CHPT) at an Outperform rating with a